News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CryoPort, Inc. To Present At The Aegis Healthcare & Technology Conference On September 12, 2014


9/3/2014 4:04:23 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAKE FOREST, Calif., Sept. 2, 2014 /PRNewswire/ -- Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that its Chief Financial Officer, Robert Stefanovich, is scheduled to present at the Aegis Healthcare & Technology Conference on Friday, September 12, 2014 at 1:30 pm PT, at The Encore at Wynn Las Vegas.

During his presentation at the conference, Mr. Stefanovich will discuss the ways in which Cryoport is experiencing significant interest and demand for its innovative cryogenic logistics solutions in the life sciences industry. Cryoport's solutions assure both its clients and their end-users that the integrity of their commodities are appropriately maintained and provide clear visibility throughout the entire documented logistics process. Cryoport understands the challenges life sciences companies experience when shipping frozen biologics and virtually eliminates the logistics risks through its reliable and innovative solutions. Its solutions combine validated packaging with the most advanced cloud-based Logistics Management Platform in the cryogenic logistics space.

Investors who wish to meet with Mr. Stefanovich for a one-on-one meeting during the conference should contact KCSA Strategic Communications at cryoport@kcsa.com or 212.682.6300.

For more information and registration, please visit the conference website: http://www.bit.ly/AegisConference.

About Cryoport, Inc.

Cryoport provides leading edge cryogenic logistics solutions to the life sciences industry through the combination of purpose-built proprietary packaging, advanced information technology and highly skilled logistics expertise which manages the entire cold chain logistics process. Cryoport Express® liquid nitrogen dry vapor shippers are validated to maintain a constant -150 degrees C temperature for a 10-plus day dynamic shipment duration, and its Cryoportal Logistics Management Platform assists in managing the entire logistics process, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport's total turnkey logistics solutions offer reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a "green" and environmentally friendly solution. Cryoport service options include recording the "chain of condition" and "chain of custody" for all shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes. For more information visit www.cryoport.com.

To download Cryoport's investor relations app, which offers access to SEC documents, press releases, videos, audiocasts and more, please click to download from your iPhone and iPad or Android mobile device.

Forward Looking Statements
Statements in this press release which are not purely historical, including statements regarding Cryoport, Inc.'s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, and technical development risks. The company's business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2014. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Cryoport, Inc. disclaims any obligation, and does not undertake to update or revise, any forward-looking statements in this press release.

Cryoport Contacts:
Todd Fromer / Garth Russell
tfromer@kcsa.com / grussell@kcsa.com
P: 1-212-682-6300

SOURCE Cryoport, Inc.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES